Personalized Medicine
Individual preventative medicine - the exhilarating vision for medicine in the 21st century. How do we translate the knowledge gained from deciphering the human genome and our rapidly expanding understanding of the nature of proteins into practical medical knowledge, tools and cures? It is an objective that leverages the vast capabilities of science.
National Center for Personalized Medicine
Established in 2012, the Nancy and Stephen Grand Israel National Center for Personalized Medicine (G-INCPM) is a state-of-the art research facility that provides Israeli academic, medical, and biomedical industry researchers with access to the most updated genomics, protein profiling, bioinformatics, drug discovery, and medicinal chemistry research platforms and know-how.
New Scientific Activities
Developing in-house automated protocols for RNA analysis for decreased cost and increased efficiency. Recently, The Weizmann Institute began implementing a protocol that enables researchers to assess the expression of genes in single cells. This protocol will facilitate the discovery of numerous genomic indicators of disease risk.
High-Throughput Screening (HTS)
The Compound Management Laboratory of the Maurice and Vivienne Wohl Institute for Drug Discovery recently completed the expansion of its compound library with the purchase of an additional 100,000 compounds. Compounds help ensure the Laboratory provides the best chemical materials for screening, to help identify “hits” through high-throughput screening (HTS).
Give them the freedom to dream and this is what happens...
Science Stories, News From The Institute
A new approach to tailoring cancer therapy: tapping into signaling activities in cancer cells
Newsletter, Science Stories, News From The Institute
Blocking children’s bone cancer
Press Release | Science Stories
Researchers at the Weizmann Institute of Science have shown in mice that intestinal microbes, collectively termed the gut microbiome, may affect the course of amyotrophic...
Science Stories
MM is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies and fighting infection.
Science Stories
A cancer research project conducted recently at the Weizmann Institute of Science evokes an unusual image: hippos. The research is not about the weighty, mud-basking...
Science Stories | News From The Institute
Our gut microbiome – the complement of bacteria we carry around in our intestines – has been linked to everything from obesity and diabetes to...
News From The Institute | Science Stories
Steba Biotech, a privately-owned company, in collaboration with scientists at the Weizmann Institute of Science, has conduct extensive research and development on TOOKAD®, and has...
Science Stories
On November 7 at the International Board, Prof. Robert Fluhr delivered a lecture entitled “The Revolution is Here,” about how technology and the wealth of...